The global hormone replacement therapy market is expected to reach $25B by 2027--up from $18B in 2022., according to a report by Research & Markets.
Over the years, hormone replacement therapy has been widely used to treat disorders associated with menopause in women, which has positively influenced the reduction of hot flashes, risks of osteoporosis, and other menopause symptoms. Certain factors positively affecting the growth of hormone replacement therapy (HRT) are increasing awareness of postmenopausal issues among women, hormonal imbalance disorders with the rising geriatric population, and a rise in drug development with novel delivery systems.
According to the UN, the global population will grow by 8.5 billion in 2030 and 9.7 billion in 2050. Common problems include weight gain, fatigue, memory decline, low libido, aging appearance, and muscle loss. However, the dangers of HRT vary with the Type, dose, and route of administration, use duration, and initiation age.